Natural History of Clostridioides Difficile Infection

Sponsor
Hospital Universitario de Valme (Other)
Overall Status
Recruiting
CT.gov ID
NCT04801862
Collaborator
(none)
750
15
35.9
50
1.4

Study Details

Study Description

Brief Summary

Aim: To investigate if host factors, such as composition and diversity of intestinal microbiota and/or genetic determinants, are associated with a higher risk of recurrence of Clostridioides difficile infection (CDI). To generate a predictive tool based on epidemiological, clinical, genetic and microbiologic variables aimed to identify patients at a higher risk of CDI recurrence in a context of optimized ICD management. Design: Multicenter prospective cohort study. Patients: Older than 18 years patients with CDI diagnosis, made by IDSA criteria, in the participant centers.

Follow-up: A stewarship program aimed to improve CDI management, including early detection of CDI recurrence, will be implemented in the participant centers. Blood samples for genetic testing and stool samples for intestinal microbiome studies will be collected.

Variables and data analysis: The primary outcome variable will be the emergence of CDI recurrence. Potential independent predictors of recurrence, including genetic and microbiological factors, will be assessed. A predictive tool based on independent predictors of recurrence will be built in a development subpopulation. The performance of the model will be assessed by ROC curves, and sensititvity, especificity, as well as negative and positive predictive values will be calculated, both in the development subpopulation and in a validation subset.

Study Design

Study Type:
Observational [Patient Registry]
Anticipated Enrollment :
750 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Clinical, Microbiological and Genetic Factors Associated With Recurrence of Clostridioides Difficile Infection and Development of a Predictive Tool for Recurrence
Actual Study Start Date :
Jan 1, 2021
Anticipated Primary Completion Date :
Jun 30, 2023
Anticipated Study Completion Date :
Dec 31, 2023

Arms and Interventions

Arm Intervention/Treatment
Patients diagnosed of C.difficile infection

Open cohort of consecutive patients diagnosed of Clostridioides difficile infection

Outcome Measures

Primary Outcome Measures

  1. CDI recurrence [First 8 weeks after end of therapy]

    Clostridioides difficile recurrence

  2. CDI reinfection [Between 8 weeks after end of therapy and before 24 weeks]

    New episode of Clostridioides difficile infection

Secondary Outcome Measures

  1. Readmission due to CDI infection [During 24 weeks after the end of therapy]

    New hospitalization related to new Clostridioides difficile infection episode

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age older than 18 years

  • New episode of Clostridioides difficile infection, based on IDSA criteria.

Exclusion Criteria:
  • None

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hospital Vega Baja Orihuela Alicante Spain
2 Hospital Marina Baixa Villajoyosa Alicante Spain
3 Hospital Universitario de Puerto Real Puerto Real Cadiz Spain
4 Hospital General Universitario de Alicante Alicante Spain
5 Hospital Universitario San Juan Alicante Spain
6 Hospital Universitario Reina Sofía Córdoba Spain
7 Hospital Universitario San Cecilio Granada Spain
8 Hospital Juan Ramón Jiménez Huelva Spain
9 Hospital Regional Universitario de Málaga Málaga Spain
10 Hospital Universitario Virgen de la Victoria Málaga Spain
11 Hospital Universitario de Valme Sevilla Spain
12 Hospital Universitario Virgen Macarena Sevilla Spain
13 Consorcio Hospital General de Valencia Valencia Spain
14 Hospital Clínico Universitario de Valencia Valencia Spain
15 Hospital Politécnico Universitario La Fe de Valencia Valencia Spain

Sponsors and Collaborators

  • Hospital Universitario de Valme

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Nicolás Merchante, Coordinator of the UCEIM-HUV Research Group, Hospital Universitario de Valme
ClinicalTrials.gov Identifier:
NCT04801862
Other Study ID Numbers:
  • PI20/01450
First Posted:
Mar 17, 2021
Last Update Posted:
Nov 5, 2021
Last Verified:
Nov 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Nicolás Merchante, Coordinator of the UCEIM-HUV Research Group, Hospital Universitario de Valme
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 5, 2021